282: Lilly’s obesity drug, the power of radiation, & a biotech implosion
The Readout Loud
00:00
Updates in the Pharmaceutical Industry
The hosts discuss the recent updates in the pharmaceutical industry, including the leading positions of Lilly and Novo. They also talk about Pfizer's oral GLP1 drug candidate and the market opportunity it presents. The chapter concludes with a mention of Ventix's biotech blowout and the larger issue of drug development in crowded fields.
Transcript
Play full episode
